Synap
The idea for Synap started with James Gupta and Omair Vaiyani both medical students at the University of Leeds, England when they were looking for a more effective way to study for their own exams. The pair learnt how to code, and built a basic website and app called MyCQs which allowed students to create, practice and share their own Multiple Choice Question (MCQ) tests online, and practice them on their smartphones.
The original intention was to create something that would help them and other people in their university as a fun project one summer, but MyCQs amassed over 13,000 downloads in under six hours, from a whole range of people across the world. Use of the app has been strong ever since, with users creating over 200,000 multiple choice questions between them for practically every topic under the sun. James and Omair continued to add features to the site, learning more about the processes involved in learning and incorporating them into MyCQs over time.
Synap is both a natural evolution and a significant improvement of our work on MyCQs. It is a platform were working on that will completely change the way students and professionals study. With a successful crowdfunded investment raise of £200,000, we have huge plans for Synap in 2016.
Articles about Synap:
- February 21, 2024 London-based Samphire Neuroscience raises €2.1 million to launch wearable that targets PMS and menstrual pain
- February 9, 2024 Weekly funding round-up! All of the European startup funding rounds we tracked this week (February 05 – 09)
- June 6, 2023 Meet Agrodox, the winner of this year’s Pitch Night in Vienna!
- December 20, 2022 Ten of the biggest acquisition deals we tracked in Europe this year!
- March 4, 2022 Weekly VC Overview: The 158 European startup funding rounds we tracked this week (Feb 28-March 4)
- November 2, 2021 64 Top Robotics Startups and Companies in Germany
- April 10, 2020 North Macedonia: Skopje’s startup ecosystem at a glance
- March 19, 2019 Bordeaux-based Synapse Medicine raises €2.5 million for its AI-based drug prescription platform